EMBL scientists uncover potential use of an FDA-approved over-the-counter cough syrup ingredient to treat fibrotic lung disease. A common ingredient in many over-the-counter cough syrups, dextromethorphan, may hold promise as a treatment for lung fibrosis—a condition associated with various serious health issues. Researchers from EMBL Heidelberg, working in collaboration with other scientists, have identified dextromethorphan […]